Concepedia

Andreas Lindauer

AL

11

Publications

904

Citations

10

H-Index

2008

Active since

Affiliations

University of Bonn(Current)

University of Cologne

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Vienna

Andreas Lindauer is an author at University of Bonn specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2008–2020

11

Publications

11

Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study

Frederike Lentz, Anne Drescher, Andreas Lindauer et al. · Anti-Cancer Drugs · 2009 · 236 citations

Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors

Paola Di Gion, Friederike Kanefendt, Andreas Lindauer et al. · Clinical Pharmacokinetics · 2011 · 214 citations

, , +3

Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose-Range Selection of the Anti-PD-1 Antibody Pembrolizumab

Andreas Lindauer, CR Valiathan, Khamir Mehta et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 117 citations · Full text

, , +20

Using Model-Based “Learn and Confirm” to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial

Jeroen Elassaiss‐Schaap, Stefaan Rossenu, Andreas Lindauer et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 112 citations · Full text

, , +21

Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab-Treated Advanced Melanoma

MS Chatterjee, Jeroen Elassaiss‐Schaap, Andreas Lindauer et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 79 citations · Full text

, , +18

Rows per page

1–5 of 11